1,064 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
JNJ Johnson & Johnson $139.96 $375.48B N/A
Article Searches
Company News For Mar 15, 2019 http://www.zacks.com/stock/news/359794/company-news-for-mar-15-2019?cid=CS-ZC--359794 Mar 15, 2019 - Companies In The News Are: BA, DG, JNJ, WAGE
Johnson & Johnson (JNJ) Presents at Barclays Global Healthcare Broker Conference Call - (Transcript) https://seekingalpha.com/article/4248819-johnson-and-johnson-jnj-presents-barclays-global-healthcare-broker-conference-call-transcript?source=feed_sector_healthcare Mar 14, 2019 - Johnson & Johnson (NYSE:JNJ) Barclays Global Healthcare Conference Call March 14, 2019, 10:15 ET Company Participants Lesley Fishman - IR Chris DelOrefice - VP, IR Catherine Owen - President, Immu
Bayer Submits Application in EU for Prostate Cancer Drug http://www.zacks.com/stock/news/358754/bayer-submits-application-in-eu-for-prostate-cancer-drug?cid=CS-ZC-FT-358754 Mar 11, 2019 - Bayer (BAYRY) submits an MAA for darolutamide in EU for the treatment of patients with non-metastatic castration-resistant prostate cancer.
Can Smart Beta & Factor ETFs Beat the Market? http://www.zacks.com/stock/news/358467/can-smart-beta-factor-etfs-beat-the-market?cid=CS-ZC-FT-358467 Mar 08, 2019 - Here is what investors need to know about smart beta and factor strategies that combine the best aspects of active and passive investing.
Can Smart Beta & Factor ETFs Beat the Market? http://www.zacks.com/stock/news/357973/can-smart-beta-factor-etfs-beat-the-market?cid=CS-ZC-FT-357973 Mar 06, 2019 - Here is what investors need to know about smart beta and factor strategies that combine the best aspects of active and passive investing.
J&J's (JNJ) Nasal Spray Spravato Gets FDA Nod for Depression http://www.zacks.com/stock/news/357836/jjs-jnj-nasal-spray-spravato-gets-fda-nod-for-depression?cid=CS-ZC-FT-357836 Mar 06, 2019 - J&J (JNJ) gets FDA nod for its new nasal spray, Spravato (esketamine) for treatment-resistant depression
The Zacks Analyst Blog Highlights: Facebook, Johnson & Johnson, JPMorgan, Sun Life and Evergy http://www.zacks.com/stock/news/357595/the-zacks-analyst-blog-highlights-facebook-johnson-johnson-jpmorgan-sun-life-and-evergy?cid=CS-ZC-FT-357595 Mar 04, 2019 - The Zacks Analyst Blog Highlights: Facebook, Johnson & Johnson, JPMorgan, Sun Life and Evergy
The 3 Oldest Members of Biotech's Billion-Burned Club https://www.fool.com/investing/2019/03/03/the-3-oldest-members-of-biotechs-billion-burned-cl.aspx?source=iedfolrf0000001 Mar 03, 2019 - These biopharmaceutical startups have been losing their investors' money for decades.
Top Stock Reports for Facebook, Johnson & Johnson & JPMorgan http://www.zacks.com/research-daily/217355/top-stock-reports-for-facebook-johnson-johnson-jpmorgan?cid=CS-ZC-FT-217355 Mar 01, 2019 - Top Stock Reports for Facebook, Johnson & Johnson & JPMorgan
3 Stocks to Buy Ahead of the Next Market Crash https://www.fool.com/investing/2019/02/28/3-stocks-to-buy-ahead-of-the-next-market-crash.aspx?source=iedfolrf0000001 Feb 28, 2019 - These three titans of their respective industries should be able to weather nearly any market environment.

Pages: 123456789101112...107

<<<Page 7>